HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.

Abstract
Activation of Wnt/β-catenin signalling is frequently observed in many types of cancer including hepatocellular carcinoma (HCC). We recently reported that cullin 4B (CUL4B), a scaffold protein that assembles CRL4B ubiquitin ligase complexes, is overexpressed in many types of solid tumours and contributes to epigenetic silencing of tumour suppressors. In this study, we characterized the function of CUL4B in HCC and investigated whether CUL4B is involved in the regulation of Wnt/β-catenin signalling. CUL4B and β-catenin were frequently up-regulated and positively correlated in HCC tissues. CUL4B activated Wnt/β-catenin signalling by protecting β-catenin from GSK3-mediated degradation, achieved through CUL4B-mediated epigenetic silencing of Wnt pathway antagonists. Knockdown of CUL4B resulted in the up-regulation of Wnt signal antagonists such as DKK1 and PPP2R2B. Simultaneous knockdown of PPP2R2B partially reversed the down-regulation of β-catenin signalling caused by CUL4B depletion. Furthermore, CRL4B promoted the recruitment and/or retention of PRC2 at the promoters of Wnt antagonists and CUL4B knockdown decreased the retention of PRC2 components as well as H3K27me3. Knockdown of CUL4B reduced the proliferation, colony formation, and invasiveness of HCC cells in vitro and inhibited tumour growth in vivo, and these effects were attenuated by introduction of exogenous β-catenin or simultaneous knockdown of PPP2R2B. Conversely, ectopic expression of CUL4B enhanced the proliferation and invasiveness of HCC cells. We conclude that CUL4B can up-regulate Wnt/β-catenin signalling in human HCC through transcriptionally repressing Wnt antagonists and thus contributes to the malignancy of HCC.
AuthorsJupeng Yuan, Bo Han, Huili Hu, Yanyan Qian, Zhaojian Liu, Zhao Wei, Xiaohong Liang, Baichun Jiang, Changshun Shao, Yaoqin Gong
JournalThe Journal of pathology (J Pathol) Vol. 235 Issue 5 Pg. 784-95 (Apr 2015) ISSN: 1096-9896 [Electronic] England
PMID25430888 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Chemical References
  • CTNNB1 protein, human
  • CUL4B protein, human
  • Cullin Proteins
  • Nerve Tissue Proteins
  • beta Catenin
  • Glycogen Synthase Kinase 3
  • PPP2R2B protein, human
  • Protein Phosphatase 2
Topics
  • Carcinoma, Hepatocellular (enzymology, genetics, pathology)
  • Cell Movement
  • Cell Proliferation
  • Cullin Proteins (genetics, metabolism)
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic
  • Glycogen Synthase Kinase 3 (metabolism)
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms (enzymology, genetics, pathology)
  • Neoplasm Invasiveness
  • Nerve Tissue Proteins (genetics, metabolism)
  • Protein Phosphatase 2 (genetics, metabolism)
  • Proteolysis
  • Time Factors
  • Transcription, Genetic
  • Transfection
  • Tumor Burden
  • Wnt Signaling Pathway
  • beta Catenin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: